---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-26-001479"
form_type: "8-K"
ticker: "SRTS"
cik: "0001494891"
company_name: "Sensus Healthcare, Inc."
filed_at: "2026-08-13T20:13:36+00:00"
generated_at: "2026-08-13T20:15:28.795712+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Sensus Healthcare Q2 revenue down 68.5% to $2.3M; net loss $8.7M

## Summary
- Revenue $2.3M vs $7.3M in Q2 2025; 11 units sold vs 19, with 8 units deferred to Q3 on financing timing.
- Net loss $8.7M ($0.53/share) vs $1.0M ($0.06/share); includes $5.7M valuation allowance on deferred tax assets.
- Adjusted EBITDA negative $3.0M vs negative $1.8M; gross margin 34.8% vs 39.7% on product mix.
- CMS proposed 26% increase in hospital-based SRT delivery code, if finalized would improve provider economics.
- Management cites strong pipeline, expanded Asia-Pacific activity (Australia, New Zealand); expects strong H2 2026.

## SEC filing metadata
- accession: 0001753926-26-001479
- form_type: 8-K
- ticker: SRTS
- cik: 0001494891
- company_name: Sensus Healthcare, Inc.
- filed_at: 2026-08-13T20:13:36+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1494891/000175392626001479/0001753926-26-001479-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1494891/000175392626001479/g085863_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-26-001479
- JSON: https://secwatch.observer/filing/0001753926-26-001479.json
- Plain text: https://secwatch.observer/filing/0001753926-26-001479.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.